The World Health Organization is sounding a critical alarm regarding the Ebola outbreak in the Democratic Republic of Congo. Two months after the epidemic was officially declared, figures released on July 15 indicate over 2,000 reported cases, tragically including 796 fatalities. However, the organization suggests that the actual number of individuals infected could be two to four times higher than these official statistics.
This significant disparity raises crucial questions: What factors contribute to such a substantial gap between reported and estimated cases? Why has this particular Ebola epidemic proven exceptionally challenging to contain? And could the recent launch of a groundbreaking post-exposure prophylaxis clinical trial in Bunia this week fundamentally alter the trajectory of this health crisis?
